UBS’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$142K Buy
4,262
+320
+8% +$10.7K ﹤0.01% 3957
2014
Q2
$127K Buy
3,942
+1,666
+73% +$53.7K ﹤0.01% 4020
2014
Q1
$105K Sell
2,276
-8,339
-79% -$385K ﹤0.01% 4104
2013
Q4
$753K Sell
10,615
-16,521
-61% -$1.17M ﹤0.01% 2801
2013
Q3
$2.33M Sell
27,136
-463
-2% -$39.7K ﹤0.01% 1825
2013
Q2
$1.75M Buy
+27,599
New +$1.75M ﹤0.01% 1967